{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Nashville",
      "state": "TN",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "75146",
      "recalling_firm": "VIRTUS PHARMACEUTICALS OPCO II L",
      "address_1": "1321 Murfreesboro Pike #",
      "address_2": "N/A",
      "postal_code": "37217-2726",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-0214-2017",
      "product_description": "Hyoscyamine Sulfate, USP Tablets, 0.125 mg, 100-count tablets per bottle, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC., Nashville, TN  37217, NDC 76439-308-10.",
      "product_quantity": "24,444 bottles",
      "reason_for_recall": "Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.",
      "recall_initiation_date": "20160902",
      "center_classification_date": "20161222",
      "termination_date": "20190923",
      "report_date": "20161228",
      "code_info": "Lot #: 30031601, 30031602, Exp 01/18"
    }
  ]
}